Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
Sotatercept for Combined Post- and Precapillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study.
Journal: Circulation
Published: March 29, 2026
Sotatercept Safety and Efficacy in Intermediate- to Low-Risk Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR.
Journal: Chest
Published: December 03, 2025
Pulmonary Hypertension Associated With Left Heart Disease: Challenges, Emerging Strategies, and Future Directions.
Journal: Journal of the American College of Cardiology
Published: November 02, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Journal: The New England journal of medicine
Published: September 30, 2025
Hypoxemia with Sotatercept.
Journal: American journal of respiratory and critical care medicine
Published: June 21, 2025
Hemodynamic Inclusion Criteria for Trials of Heart Failure With Preserved Ejection Fraction, Cardiogenic Shock, and Pulmonary Arterial Hypertension.
Journal: Journal of cardiac failure
Published: June 17, 2025
Authors' Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: May 30, 2025
Another Act in the Story of Oral Imatinib for Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: May 02, 2025
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: April 13, 2025
Pericardial effusion in sotatercept phase 3 trials: insights from STELLAR and ZENITH.
Journal: The European respiratory journal
Published: April 10, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
Journal: The New England journal of medicine
Published: April 01, 2025
Last Updated: 09/26/2026